These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 15095090

  • 1. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas.
    Soares P, Trovisco V, Rocha AS, Feijão T, Rebocho AP, Fonseca E, Vieira de Castro I, Cameselle-Teijeiro J, Cardoso-Oliveira M, Sobrinho-Simões M.
    Virchows Arch; 2004 Jun; 444(6):572-6. PubMed ID: 15095090
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. BRAF mutations in an Italian cohort of thyroid cancers.
    Fugazzola L, Mannavola D, Cirello V, Vannucchi G, Muzza M, Vicentini L, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):239-43. PubMed ID: 15272920
    [Abstract] [Full Text] [Related]

  • 5. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
    Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M.
    Virchows Arch; 2005 Jun; 446(6):589-95. PubMed ID: 15902486
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.
    Chakraborty A, Narkar A, Mukhopadhyaya R, Kane S, D'Cruz A, Rajan MG.
    Endocr Pathol; 2012 Jun; 23(2):83-93. PubMed ID: 22105775
    [Abstract] [Full Text] [Related]

  • 8. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.
    Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-Simões M.
    Hum Pathol; 2005 Jun; 36(6):694-7. PubMed ID: 16021577
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA.
    Cancer Res; 2003 Aug 01; 63(15):4561-7. PubMed ID: 12907632
    [Abstract] [Full Text] [Related]

  • 10. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
    Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M.
    Oncogene; 2003 Jul 17; 22(29):4578-80. PubMed ID: 12881714
    [Abstract] [Full Text] [Related]

  • 11. BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns.
    Jakubowski M, Hunt JL.
    Am J Surg Pathol; 2009 Nov 17; 33(11):1590-3. PubMed ID: 19738460
    [Abstract] [Full Text] [Related]

  • 12. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, Monacelli M, Macchiarulo A, Santeusanio F, Tartaglia M, Puxeddu E.
    Clin Endocrinol (Oxf); 2006 Jan 17; 64(1):105-9. PubMed ID: 16402937
    [Abstract] [Full Text] [Related]

  • 13. BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
    Gauchotte G, Philippe C, Lacomme S, Léotard B, Wissler MP, Allou L, Toussaint B, Klein M, Vignaud JM, Bressenot A.
    Pathology; 2011 Aug 17; 43(5):447-52. PubMed ID: 21716161
    [Abstract] [Full Text] [Related]

  • 14. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM, Huang YW, Huang JS, Wang CH, Kok VC, Hung CM, Chen HM, Tzen CY.
    Ann Surg Oncol; 2007 Oct 17; 14(10):3011-8. PubMed ID: 17638058
    [Abstract] [Full Text] [Related]

  • 15. Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis.
    Kim KH, Suh KS, Kang DW, Kang DY.
    Pathol Int; 2005 Sep 17; 55(9):540-5. PubMed ID: 16143028
    [Abstract] [Full Text] [Related]

  • 16. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.
    Cancer; 2005 Jun 01; 103(11):2261-8. PubMed ID: 15880523
    [Abstract] [Full Text] [Related]

  • 17. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.
    Cancer Cytopathol; 2015 Oct 01; 123(10):593-602. PubMed ID: 26230187
    [Abstract] [Full Text] [Related]

  • 18. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.
    Frattini M, Ferrario C, Bressan P, Balestra D, De Cecco L, Mondellini P, Bongarzone I, Collini P, Gariboldi M, Pilotti S, Pierotti MA, Greco A.
    Oncogene; 2004 Sep 23; 23(44):7436-40. PubMed ID: 15273715
    [Abstract] [Full Text] [Related]

  • 19. [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].
    Zhu XL, Zhou XY, Zhu XZ.
    Zhonghua Bing Li Xue Za Zhi; 2005 May 23; 34(5):270-4. PubMed ID: 16181547
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
    Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA.
    Cancer Res; 2003 Apr 01; 63(7):1454-7. PubMed ID: 12670889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.